Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
2 August 2023 |
Main ID: |
NCT02668354 |
Date of registration:
|
27/01/2016 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Cancer in Infants: South Egypt Cancer Institute Experience
|
Scientific title:
|
Cancer in Infants: South Egypt Cancer Institute Experience |
Date of first enrolment:
|
February 1, 2017 |
Target sample size:
|
250 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/ct2/show/NCT02668354 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Egypt
| | | | | | | |
Contacts
|
Name:
|
Ahmed M. Morsy, MD |
Address:
|
|
Telephone:
|
+2 01003314522 |
Email:
|
ahmedmohammed7829@yahoo.com |
Affiliation:
|
|
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients whose age less than or equal to 1 year.
- Patients diagnosed with any of malignant neoplasms.
Exclusion Criteria:
• Patients whose age more than 1 year.
Age minimum:
N/A
Age maximum:
1 Year
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Infantile Neoplasms
|
Primary Outcome(s)
|
Overall survival (OS)
[Time Frame: Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years]
|
Event Free Survival (EFS)
[Time Frame: Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years]
|
Secondary ID(s)
|
Cancer in Infants SECI
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|